Tenoxicam, an antiinflammatory agent with analgesic and antipyretic properties.
In Vitro:
Tenoxicam (Ro-12-0068) is a non-steroidal anti-inflammatory drug (NSAID).
In Vivo:
Tenoxicam (Ro-12-0068) was administered intraperitoneally immediately after BCAO. Histological analyses show that ischemia produced significant striatal as well as hippocampal lesions which were reversed by the Tenoxicam (Ro-12-0068) treatment. Tenoxicam (Ro-12-0068) also significantly reduced, to control levels, the increased myeloperoxidase activity in hippocampus homogenates observed after ischemia.
Synonyms:
Apo-Tenoxicam;
Mobiflex;
Tenoxicam;
Tenoxicamum;
4-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-ylthieno[2,3-e]thiazine-3-carboxamide;
Octiveran;
Tilcotil;
Liman;
Novo-Tenoxicam;
Properties:
Appearance & Physical State: yellow crystalline powder
Density: 1.675 g/cm3
Melting Point: 209-2130ºC
Refractive Index: 1.741
Immunology & Inflammation related Inhibitors Related Prodcuts:
Pimecrolimus; Cyclosporin A; Bestatin; GI254023X; Bindarit; TAPI-1; Avadomide; Thymopentin; Pranlukast; Laquinimod; VGX-1027; Y-320; Imiquimod; Levamisole hydrochloride; Halcinonide; Sodium gualenate; Aceclofenac; Fenoprofen calcium; Pidotimod; Etofenamate